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We would like to thank Mr Chong and colleagues for
their comments. The main point of their comments,
seem to relate to the fact that we did not include
their instrument, the ICQ, in our paper assessing
disease specific instruments for claudication. We
chose the instruments for study early in 2002 before
the ICQ was published. We were, however, aware of
the ICQ from published abstracts and did approach
the authors for permission and assistance in includ-
ing the ICQ in our studies. We did not receive a
timely response.
A small number of claudicants will deteriorate and
progress to critical ischaemia thus we are of the
opinion that any disease specific QOL instrument
should be able to detect this change. The sensitivity to
negative change of any instrument not assessing
critical ischaemia needs to be closely examined. We
are not aware of any publications comparing the ICQ
to other disease specific QOL instruments (we
consider the WIQ to be a paper treadmill test rather
than a QOL measure) thus to claim the ‘ICQ is
currently the best condition specific instrument’
requires further justification.
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We read with interest the paper from Mehta et al.
recommending the VASCUQUOL as the most
responsive disease specific instrument for evaluating
quality of life (QOL) changes in intermittent
claudication (IC).
Although we agree with the authors that one of the
main aims of treating IC is to reverse its detrimental
effect on QOL, we are rather surprised that in their
search of a suitable disease-specific instrument for this
condition, there was no evaluation of the intermittent
claudication questionnaire (ICQ) in their study. The
ICQ is a patient assessed, 16-item instrument that takes
an average time of 3.7 min to completewith a test-retest
intraclass correlation of 0.95 and Cronbach’s alpha of
0.94.1 In recently published randomised studies
evaluating the impact of treating IC, Cheetham et al.2
and Kakkos et al.3 have shown that the ICQ was
superior to the SF-36 in being able to detect subtle but
important QOL changes in claudicants following
intervention. If a suitable disease-specific instrument
is available, it may be time to abandon the use of
lengthy, non-responsive generic instruments in labour
intensive IC trials.
Although across the Atlantic, the WIQ (Walking
Impairment Questionnaire) is the preferred disease-
specific instrument for evaluation of QOL in IC, we
agreewith the authors’ conclusion in a previous review
that the WIQ is really only a measure of walking
performance and not strictly a QOL measure.4
Although walking impairment is a feature of IC,
evaluation of this function alone does not fully address
claudicants’ concerns regarding QOL impairment. For
example, a maximumwalking distance of 50 mmay be
a handicap to one patient, but may be perfectlyEur J Vasc Endovasc Surg 32, 110–111 (2006)
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